Could a simple blood swap cut transfusions in bone cancer surgery?
NCT ID NCT07669155
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether removing some blood during bone cancer surgery and replacing it with fluid (acute normovolemic hemodilution) can reduce the need for donor blood transfusions. The trial will include 420 adults undergoing elective bone cancer surgery. The goal is to see if this technique lowers transfusion rates and related complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Acute normovolemic hemodilution (a procedure where some blood is removed during surgery and replaced with fluid, then given back later)
- What this could lead to
- If it works, this technique could reduce the need for donor blood transfusions during bone cancer surgery, lowering risks and costs.
- What could go wrong
- This is an early-stage trial with no results yet. The procedure may not reduce transfusions as hoped, and there are always risks with any surgical technique.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE NORMOVOLEMIC HEMODILUTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital of Zhejiang University anesthesiology department
Hangzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.